The COVID-19 pandemic has accelerated the use of virtual care, and companies like Livongo stand to benefit financially. Livongo, a chronic disease management company that has a strong focus on diabetes, reported a 115% jump in first-quarter revenue, increasing from $32 million a year ago to $68.8 million.
